Interessenkonflikt: Der Autor ist Berater bei Zimmer Biomet und BBraun und Teilhaber der sBone-GmbH.

Korrespondenzadresse

Dr. med. Matthias Militz

Abteilung für Septische und
Rekonstruktive Chirurgie

BG Unfallklinik Murnau

Prof. Küntscher Straße 8

82418 Murnau

Matthias.Militz@bgu-murnau.de

Literatur

1. Parvizi J, Zmistowski B, Adeli B. Periprosthetic joint infection: treatment options. Orthopedics 2010; 33: 659

2. Volkmann R. [Hip implant revision. Avoiding mistakes and managing risk]. Orthopade 2009; 38: 718–28

3. Winkler T, Trampuz A, Hardt S, Janz V, Kleber C, Perka C. [Periprosthetic infection after hip arthroplasty]. Orthopade 2014; 43: 70–8

4. Parvizi J, Gehrke T, Chen AF. Proceedings of the International Consensus on Periprosthetic Joint Infection. Bone Joint J 2013; 95-B: 1450–2

5. Voleti PB, Baldwin KD, Lee GC. Use of static or articulating spacers for infection following total knee arthroplasty: a systematic literature review. J Bone Joint Surg Am 2013; 95: 1594–9

6. Kuzyk PR, Dhotar HS, Sternheim A, Gross AE, Safir O, Backstein D. Two-stage revision arthroplasty for management of chronic periprosthetic hip and knee infection: techniques, controversies, and outcomes. J Am Acad Orthop Surg 2014; 22: 153–64

7. Choi HR, Freiberg AA, Malchau H, Rubash HE, Kwon YM. The fate of unplanned retention of prosthetic articulating spacers for infected total hip and total knee arthroplasty. J Arthroplasty 2014; 29: 690–3

8. Hsieh PH, Huang KC, Tai CL. Liquid gentamicin in bone cement spacers: in vivo antibiotic release and systemic safety in two-stage revision of infected hip arthroplasty. J Trauma 2009; 66: 804–8

9. Thabe H, Schill S. Two-stage reimplantation with an application spacer and combined with delivery of antibiotics in the management of prosthetic joint infection. Oper Orthop Traumatol 2007; 19: 78–100

10. Lehner B, Witte D, Suda AJ, Weiss S. [Revision strategy for periprosthetic infection]. Orthopade 2009; 38: 681–8

11. Haaker R, Senge A, Kramer J, Rubenthaler F. [Osteomyelitis after endoprostheses]. Orthopade 2004; 33: 431–8

12. Tsung JD, Rohrsheim JA, Whitehouse SL, Wilson MJ, Howell JR. Management of Periprosthetic Joint Infection After Total Hip Arthroplasty Using a Custom Made Articulating Spacer (CUMARS); the Exeter Experience. J Arthroplasty 2014; 29: 1813–8

13. Ascherl R. [Infection management of megaimplants]. Orthopade 2010; 39: 980–93

14. Pietsch M, Wenisch C, Traussnig S, Trnoska R, Hofmann S. [Temporary articulating spacer with antibiotic-impregnated cement for an infected knee endoprosthesis]. Orthopade 2003; 32: 490–7

15. Ben-Lulu O, Farno A, Gross AE, Backstein DJ, Kosashvili Y, Safir OA. A modified cement spacer technique for infected total hip arthroplasties with significant bone loss. J Arthroplasty 2012; 27: 613–9

16. Bloomfield MR, Klika AK, Barsoum WK. Antibiotic-coated spacers for total hip arthroplasty infection. Orthopedics 2010; 33: 649

17. Neumann DR, Hofstaedter T, List C, Dorn U. Two-stage cementless revision of late total hip arthroplasty infection using a premanufactured spacer. J Arthroplasty 2012; 27: 1397–401

18. ter Boo GJ, Grijpma DW, Moriarty TF, Richards RG, Eglin D. Antimicrobial delivery systems for local infection prophylaxis in orthopedic- and trauma surgery. Biomaterials 2015; 52: 113–25

19. Uchiyama K, Takahira N, Fukushima K, Moriya M, Yamamoto T, Minegishi Y, et al. Two-stage revision total hip arthroplasty for periprosthetic infections using antibiotic-impregnated cement spacers of various types and materials. ScientificWorldJournal 2013; 2013:147248

20. Rolf O, Stehle J, Gohlke F. [Treatment of septic arthritis of the shoulder and periprosthetic shoulder infections. Special problems in rheumatoid arthritis]. Orthopade 2007; 36: 700–7

21. Stine IA, Lee B, Zalavras CG, Hatch G, III, Itamura JM. Management of chronic shoulder infections utilizing a fixed articulating antibiotic-loaded spacer. J Shoulder Elbow Surg 2010; 19: 739–48

22. Degen RM, Davey JR, Davey JR, Howard JL, McCalden RW, Naudie DD. Does a prefabricated gentamicin-impregnated, load-bearing spacer control periprosthetic hip infection? Clin Orthop Relat Res 2012; 470: 2724–9

23. Deelstra JJ, Neut D, Jutte PC. Successful treatment of Candida albicans-infected total hip prosthesis with staged procedure using an antifungal-loaded cement spacer. J Arthroplasty 2013; 28: 374–8

24. Jia YT, Zhang Y, Ding C et al. Antibiotic-loaded articulating cement spacers in two-stage revision for infected total knee arthroplasty: individual antibiotic treatment and early results of 21 cases. Chin J Traumatol 2012; 15: 212–21

25. Antoci V, Phillips MJ, Antoci V, Jr., Krackow KA. Using an antibiotic-impregnated cement rod-spacer in the treatment of infected total knee arthroplasty. Am J Orthop 2009; 38: 31–3

26. Babis GC, Zahos KA, Tsailas P, Karaliotas GI, Kanellakopoulou K, Soucacos PN. Treatment of stage III-A-1 and III-B-1 periprosthetic knee infection with two-stage exchange arthroplasty and articulating spacer. J Surg Orthop Adv 2008; 17: 173–8

27. Castelli CC, Gotti V, Ferrari R. Two-stage treatment of infected total knee arthroplasty: two to thirteen year experience using an articulating preformed spacer. Int Orthop 2014 Feb; 38: 405–12